Abbott Launches Revolutionary Biowearables for Real-Time Health Monitoring

2025-01-17 digitalcare

Chicago, Friday, 17 January 2025.
Abbott introduces biowearables that offer users real-time health insights, aiming to transform personal health management through continuous monitoring and empowering individuals in their wellness journey.

Breakthrough in Health Technology

Abbott’s latest innovation in health technology marks a significant advancement in personal health monitoring, with their biowearables utilizing coin-sized biosensors that measure vital biomarkers including glucose, ketones, and lactate [1]. The technology streams real-time data directly to users’ smartphones, providing unprecedented access to personal health metrics [1][3]. This breakthrough comes as Abbott continues to expand its presence as a global healthcare leader, serving over 114,000 employees across more than 160 countries [2].

Award-Winning Innovation

The company’s commitment to innovation has already garnered recognition, with their consumer biowearable Lingo being honored at the 2025 CES Innovations Awards in the Digital Health category on January 16, 2025 [3]. The device, which builds upon Abbott’s successful FreeStyle Libre technology currently serving over six million people globally [3], represents a significant step forward in democratizing healthcare access. During the CES 2025 showcase from January 5-10, experts highlighted how this technology empowers users to make informed decisions about their eating, sleeping, and training habits [4].

Real-World Applications and Impact

The system’s practical applications extend beyond basic health monitoring. According to Olivier Ropars, divisional vice president of Abbott’s Lingo business, ‘Glucose is a powerful signal of your body’s unique response to food and lifestyle’ [3][5]. The technology allows users to wear a biosensor for up to 14 days, providing continuous monitoring and personalized insights based on metabolic trends [5]. Research indicates that improved glucose management can benefit individuals in multiple ways, including weight management, sleep quality enhancement, and mood improvement [3].

Future of Healthcare Technology

Abbott’s biowearables represent a broader shift toward digitized, decentralized, and democratized healthcare [6]. The technology aims to bridge the gap between professional medical monitoring and personal health management, offering users unprecedented control over their wellness journey. This innovation aligns with Abbott’s mission to provide life-changing technologies across the healthcare spectrum, from diagnostics to medical devices and nutritional products [2]. The company continues to expand its reach and impact, with plans to make these technologies accessible to more users globally [alert! ‘specific future expansion plans not detailed in sources’].

Bronnen

biowearables biosensors